Request for Covid-19 Impact Assessment of this Report

Take Action
Diagnostic and Biotech

Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Size study, by Product (Instruments, Reagent, Services), by Technology (Immunoassay, Molecular Diagnostics, Microbiology, Others), by Application (Streptococcus, Clostridium Difficile, Carbapenem-resistant enterobacterial testing (CRE), Respiratory virus, Tuberculosis (TB) & drug-resistant TB, Human Immunodeficiency Virus (HIV), Gonorrhea, Chlamydia, Others), by End-Use (Point of Care, Central Laboratories, Others) and Regional Forecasts 2020-2027

  • BIZ4259121
  • 200 Pages
  • March 2021
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Global Infectious Diseases in-Vitro Diagnostics (IVD) Market is valued at approximately USD 54 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.8% over the forecast period 2020-2027. Infectious Diseases in-Vitro Diagnostics (IVD) is a type of medical devices, which needs the use of reagents and assays to treat a medical condition. The information shown through these diagnostic tools helps physicians in productive management of medical settings in each stage. In addition, the use and handling of in-vitro diagnostics needs significant technical expertise, and therefore, instruments are utilized in specific medical facilities to perform a diagnosis of diseases. For example, infectious diseases IVD products are frequently using in many healthcare facilities, such as point-of care centers, standalone laboratories, and hospitals. Moreover, there have been significant developments have been advanced in these products that have enabled a paradigm shift from point of care testing to laboratory testing, which is assisting in expansion of infectious diseases IVD market. Furthermore, the rise in prevalence of infectious diseases in the developed and developing region, along with the increasing government support and consumer awareness in regards of faster diagnostics are the few factors responsible for the high CAGR of the market during the forecast period. For instance, according to the Avert organization, in 2018, nearly 37.9 million individuals were affected by HIV (including 1.7 million children), with a global prevalence rate of HIV is estimated nearly 0.8% among adults. Similarly, the U.S. Department of Health & Human Services has valued about 21.7 million people living with HIV in 2017, signifying a surge of 2.3 million from 2016. Likewise, as per the survey of Center for Disease Control and Prevention, the symptomatic illness of influenza in the US is nearly 30,000,000 during 2016-17 and is increased to approximately 49,000,000 in 2017-18. This, in turn, is likely to strengthen the demand for Infectious Diseases in-Vitro Diagnostics (IVD) products, globally. However, the high prices of IVD testing is one of the major factors limiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Infectious Diseases in-Vitro Diagnostics (IVD) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising demand for the Point-of-care and molecular diagnostic devices, along with the rise in presence of market vendors in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as growing prevalence of infectious diseases along with growing healthcare infrastructure in developing countries, such as China and India, are the few factors creating lucrative growth opportunities for the Infectious Diseases in-Vitro Diagnostics (IVD) market in the region.

Major market player included in this report are:

Becton, Dickinson and Company

BioMérieux SA

Abbott Laboratories

Quidel Corporation

OraSure Technologies, Inc.

Hologic Inc. (Gen Probe)

Qiagen

F. Hoffmann-La Roche Ltd.

Siemens Healthcare GmbH

Bio-Rad Laboratories, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Instruments

Reagent

Services

By Technology:

Immunoassay

Molecular Diagnostics

Microbiology

Others

By Application:

Streptococcus

Clostridium Difficile

Carbapenem-resistant enterobacterial testing (CRE)

Respiratory virus

Tuberculosis (TB) & drug-resistant TB

Human Immunodeficiency Virus (HIV)

Gonorrhea

Chlamydia

Others

By End-Use:

Point of Care

Central Laboratories

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Infectious Diseases in-Vitro Diagnostics (IVD) Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Region, 2018-2027 (USD Billion)

1.2.2. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product, 2018-2027 (USD Billion)

1.2.3. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology, 2018-2027 (USD Billion)

1.2.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application, 2018-2027 (USD Billion)

1.2.5. Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Dynamics

3.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Product

5.1. Market Snapshot

5.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Product, Performance - Potential Analysis

5.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Product 2017-2027 (USD Billion)

5.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis

5.4.1. Instruments

5.4.2. Reagent

5.4.3. Services

Chapter 6. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Technology

6.1. Market Snapshot

6.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Technology, Performance - Potential Analysis

6.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)

6.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis

6.4.1. Immunoassay

6.4.2. Molecular Diagnostics

6.4.3. Microbiology

6.4.4. Others

Chapter 7. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by Application

7.1. Market Snapshot

7.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by Application, Performance - Potential Analysis

7.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by Application 2017-2027 (USD Billion)

7.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis

7.4.1. Streptococcus

7.4.2. Clostridium Difficile

7.4.3. Carbapenem-resistant enterobacterial testing (CRE)

7.4.4. Respiratory virus

7.4.5. Tuberculosis (TB) & drug-resistant TB

7.4.6. Human Immunodeficiency Virus (HIV)

7.4.7. Gonorrhea

7.4.8. Chlamydia

7.4.9. Others

Chapter 8. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, by End-Use

8.1. Market Snapshot

8.2. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market by End-Use - Potential Analysis

8.3. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)

8.4. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Sub Segment Analysis

8.4.1. Point of Care

8.4.2. Central Laboratories

8.4.3. Others

Chapter 9. Global Infectious Diseases in-Vitro Diagnostics (IVD) Market, Regional Analysis

9.1. Infectious Diseases in-Vitro Diagnostics (IVD) Market, Regional Market Snapshot

9.2. North America Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.2.1. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.2.1.1. Product breakdown estimates & forecasts, 2017-2027

9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027

9.2.1.3. Application breakdown estimates & forecasts, 2017-2027

9.2.1.4. End-Use breakdown estimates & forecasts, 2017-2027

9.2.2. Canada Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.3. Europe Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot

9.3.1. U.K. Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.3.2. Germany Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.3.3. France Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.3.4. Spain Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.3.5. Italy Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.3.6. Rest of Europe Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.4. Asia-Pacific Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot

9.4.1. China Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.4.2. India Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.4.3. Japan Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.4.4. Australia Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.4.5. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.4.6. Rest of Asia Pacific Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.5. Latin America Infectious Diseases in-Vitro Diagnostics (IVD) Market Snapshot

9.5.1. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.5.2. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) Market

9.6. Rest of The World Infectious Diseases in-Vitro Diagnostics (IVD) Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Becton, Dickinson and Company

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. BioMérieux SA

10.2.3. Abbott Laboratories

10.2.4. Quidel Corporation

10.2.5. OraSure Technologies, Inc.

10.2.6. Hologic Inc. (Gen Probe)

10.2.7. Qiagen

10.2.8. F. Hoffmann-La Roche Ltd.

10.2.9. Siemens Healthcare GmbH

10.2.10. Bio-Rad Laboratories, Inc.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Infectious Diseases in-Vitro Diagnostics (IVD) market, report scope

TABLE 2. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by region 2017-2027 (USD Billion)

TABLE 3. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by Product 2017-2027 (USD Billion)

TABLE 4. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by Technology 2017-2027 (USD Billion)

TABLE 5. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by Application 2017-2027 (USD Billion)

TABLE 6. Global Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by End-Use 2017-2027 (USD Billion)

TABLE 7. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 17. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 18. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 20. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 21. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 22. Global Infectious Diseases in-Vitro Diagnostics (IVD) market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 23. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 24. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 25. U.S. Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 26. Canada Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 27. Canada Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 28. Canada Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 29. UK Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 30. UK Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 31. UK Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 32. Germany Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 33. Germany Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 34. Germany Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 35. France Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 36. France Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 37. France Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 38. Spain Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 39. Spain Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 40. Spain Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 41. Italy Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 42. Italy Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 43. Italy Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 44. ROE Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 45. ROE Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 46. ROE Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 47. China Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 48. China Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 49. China Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 50. India Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 51. India Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 52. India Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 53. Japan Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 54. Japan Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 55. Japan Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 56. Australia Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 57. Australia Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 58. Australia Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 59. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 60. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 61. South Korea Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 62. ROPAC Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 63. ROPAC Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 64. ROPAC Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 65. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 66. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 67. Brazil Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 68. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 69. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 70. Mexico Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 71. ROLA Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 72. ROLA Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 73. ROLA Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 74. ROW Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 75. ROW Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 76. ROW Infectious Diseases in-Vitro Diagnostics (IVD) market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 77. List of secondary sources, used in the study of global Infectious Diseases in-Vitro Diagnostics (IVD) market

TABLE 78. List of primary sources, used in the study of global Infectious Diseases in-Vitro Diagnostics (IVD) market

TABLE 79. Years considered for the study

TABLE 80. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research